Imagin Medical Stock Gross Profit
| IMEXF Stock | USD 0.0001 0.00 0.00% |
Imagin Medical fundamentals help investors to digest information that contributes to Imagin Medical's financial success or failures. It also enables traders to predict the movement of Imagin Pink Sheet. The fundamental analysis module provides a way to measure Imagin Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Imagin Medical pink sheet.
Imagin |
Imagin Medical Company Gross Profit Analysis
Imagin Medical's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
| Competition |
According to the company disclosure, Imagin Medical reported 0.0 of gross profit. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Devices industry. The gross profit for all United States stocks is 100.0% higher than that of the company.
Imagin Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Imagin Medical's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Imagin Medical could also be used in its relative valuation, which is a method of valuing Imagin Medical by comparing valuation metrics of similar companies.Imagin Medical is currently under evaluation in gross profit category among its peers.
Imagin Fundamentals
| Return On Asset | -2.37 | |||
| Current Valuation | 7.9 M | |||
| Shares Outstanding | 10.83 M | |||
| Shares Owned By Insiders | 12.46 % | |||
| Price To Earning | (3.47) X | |||
| Price To Book | 9.05 X | |||
| EBITDA | (2.44 M) | |||
| Net Income | (2.49 M) | |||
| Cash And Equivalents | 145.67 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 8.95 M | |||
| Debt To Equity | 2.10 % | |||
| Current Ratio | 0.04 X | |||
| Book Value Per Share | (1.23) X | |||
| Cash Flow From Operations | (2.63 M) | |||
| Earnings Per Share | (0.90) X | |||
| Number Of Employees | 15 | |||
| Beta | 1.5 | |||
| Market Capitalization | 1.84 M | |||
| Total Asset | 1.35 M | |||
| Z Score | -3.3 | |||
| Net Asset | 1.35 M |
About Imagin Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Imagin Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Imagin Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Imagin Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Imagin Pink Sheet
Imagin Medical financial ratios help investors to determine whether Imagin Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Imagin with respect to the benefits of owning Imagin Medical security.